Travere Therapeutics logo

Senior Manager, Patient Advocacy & Insights Integration

Travere Therapeutics

San Diego, CAOnsitePosted 1 day ago$132,000 - $172,000/year
Full TimeSenior LevelMedical AffairsBiotechnology
Original posting ↗

Summary

The Senior Manager, Patient Advocacy & Insights Integration is responsible for the day-to-day operational planning and execution of designated FILSPARI Patient Advocacy priorities across IgA nephropathy (IgAN) and focal segmental glomerulosclerosis (FSGS). This role manages assigned renal patient advocacy organization relationships, programs, patient-centered content, and agency deliverables and develops the workflows, project plans, and tools needed to support consistent, timely execution. Approximately 25% of the role is dedicated to coordinating the Rare Disease Patient Advisory Council (RDPAC) across Renal, Metabolic, and future rare disease programs.

Job description

Responsibilities

FILSPARI Advocacy Operations and Execution

  • Operationalize designated FILSPARI priorities across IgAN and FSGS by creating workplans and maintaining timelines, budgets, deliverables, and measures.
  • Coordinate assigned FILSPARI programs and deliverables from planning through execution, evaluation, documentation, and closeout; provide routine status updates and promptly flag risks and decisions requiring input.
  • Track patient and community needs, access challenges, and relevant external developments; summarize findings for the team's consideration in planning.

External Relationships and Patient Engagement

  • Coordinate ongoing engagement with assigned IgAN and FSGS patient organizations and stakeholders, preparing engagement plans and materials in alignment with the team's priorities.
  • Manage approved, compliant advocacy activities, including educational resources, advisory sessions, and patient and caregiver engagement.
  • Organize team participation at renal conferences and programs.
  • Participate in assigned meetings and programs, sharing updates or presenting when requested.
  • Engage patients and families with empathy, humility, active listening, and respect.

Patient Insights and Cross-Functional Integration

  • Systematize RDPAC operations across Renal, Metabolic, and future rare disease programs, including the creation of workplans, meeting calendars, agendas, and materials while managing member communications, logistics, and follow-up with therapeutic leads.
  • Support the consistent capture and synthesis of RDPAC and other patient and care partner insights; document relevant implications, owners, and actions, and prepare concise summaries for discussion.
  • Administer insight sharing and agreed follow-up with Medical Affairs, Commercial, Market Access, Patient Services, Clinical Development, HEOR, Communications, Government Affairs, Patient Marketing, and other partners, within Patient Advocacy's role and compliance boundaries.

Patient-Centered Content and Agency Leadership

  • Serve as the day-to-day point of contact and operational lead for agency deliverables.
  • Coordinate briefs, scopes, timelines, budgets, deliverables, internal feedback, and routine performance follow-up; escalate strategic decisions or material concerns to the Director.
  • Monitor and document patient, partner, access, and external developments to identify content and engagement needs, intended outcomes, activation, and evaluation for assigned initiatives; share findings and recommend practical improvements.
  • Contribute to patient-centered materials and resources, gather input from patients, partners, internal experts, and agencies, and manage review workflows to ensure accuracy and compliance.
  • Follow applicable legal, regulatory, compliance, privacy, and disclosure requirements in all activities and interactions.

Requirements

  • Bachelor's degree in social science, public health, healthcare, communications, business, or a related field
  • At least 5 years of progressive experience in biopharmaceutical, healthcare, nonprofit, or patient advocacy environment
  • At least 2 years of relevant experience in rare disease, patient advocacy, or external stakeholder engagement
  • Experience working cross-functionally and managing complex projects, external agencies or vendors, budgets, timelines, and multiple priorities
  • Demonstrated ability to develop operational tools, workflows, and project management processes
  • Working understanding of drug research and development, marketed-product considerations, and legal, regulatory, and compliance environment for patient advocacy
  • Strong communication, networking, interpersonal, presentation, and public-speaking skills
  • Ability to build trust with a wide range of stakeholders
  • Excellent listening skills and ability to translate complex concepts
  • Demonstrated passion for supporting patient and underserved communities
  • Track record in project and program management, organization, prioritization, and follow-through
  • Ability to collaborate effectively across functions and levels of influence
  • Sound judgment, emotional intelligence, adaptability
  • Ability to travel approximately 35 to 45 percent domestically

Benefits

  • Health Insurance
  • Financial Offerings
  • Wellness Programs
  • Employee Support Programs
  • Life Insurance
  • Disability Insurance
  • Retirement Plans
  • Employer Match
  • Paid Time Off
  • Short-Term Incentive
  • Long-Term Incentive Compensation

Company overview

Travere Therapeutics is a biopharmaceutical company headquartered in San Diego, California, dedicated to identifying, developing, and delivering life-changing therapies for people living with rare kidney and metabolic diseases. Founded in 2011 as Retrophin and rebranded as Travere Therapeutics in 2020, the company has established itself as a leader in rare disease therapeutics with a focused pipeline targeting conditions with significant unmet medical needs. Their flagship product, FILSPARI® (sparsentan), received full FDA approval in September 2024 to slow kidney function decline in adults with primary IgA nephropathy (IgAN) who are at risk for disease progression. The company also has a Phase 3 clinical program for pegtibatinase (TVT-058) targeting classical homocystinuria (HCU), a rare genetic metabolic disorder. Travere maintains a commercial portfolio including Thiola EC® and Thiola® for cystinuria, demonstrating their commitment to serving rare disease communities through comprehensive therapeutic solutions. With a global presence and strategic partnerships, Travere Therapeutics continues to advance innovative treatments while supporting patient access and education initiatives for rare disease populations.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.